American Recovery and Reinvestment Act
EMSL researchers are benefitting from a recent $60 million investment in innovation through the American Recovery and Reinvestment Act. These Recovery Act funds were employed to further develop and deploy transformational capabilities that deliver scientific discoveries in support of DOE's mission. Today, they are helping EMSL accomplish the following:
- Establish leadership in in situ chemical imaging and procure ultrahigh-resolution microscopy tools
- Investing in Innovation: EMSL and the American Recovery and Reinvestment Act
- Recovery Act and Systems Biology at EMSL
- Recovery Act Instruments coming to EMSL
- Acquire next-generation mass spectrometry capabilities with unparalleled sensitivity and dynamic range
- Obtain nuclear magnetic resonance capabilities for high-field radiological and environmental/catalysis applications
- Advance its computational chemistry software, NWChem, toward exascale computing
- Retain and grow a talented scientific workforce with established and specialized scientific expertise
- Promote a path toward a solid economic recovery.
In the News
Taken together with additional major acquisitions that are part of EMSL's constant commitment to evolve with the needs of its scientific users, Recovery Act investments offer researchers new tools that push the frontiers of instrument resolution and sensitivity. In addition, these resources increasingly allow scientists to examine chemical and biological systems in their native environments and under dynamic conditions. Examples include:
- Mass spectrometers that allow top-down proteomics with a 21-T ICR-MS and high throughput-omics experiments
- Seven new electron microscopes, including two aberration-corrected TEMs, two dual-beam SEMs, an atom probe, and a He+ microscope in a new "quiet" wing as well as STORM, an optical microscope with nanoscale resolution
- A comprehensively equipped radiological facility
- New high-field magnetic resonance (NMR and EPR) capabilities and specialty probes
- Integrated systems-microbiology and extremophile capabilities, including transcriptomics, flow cytometry, and imaging
- State-of-the-art surface characterization capabilities, including nano-SIMS and XPS imaging as well as next-generation oxygen-plasma assisted molecular beam epitaxy
- Microfluidics manipulation and manufacturing.
Learn more detail about Recovery Act Instruments at EMSL.